Figure 1.

Subgroup analyses of MGQoL15 and MGADL stratified by relevant fatigue and disease classification. MGQoL15 and MGADL scores are significantly higher in patients with relevant fatigue. Within the group of patients with relevant fatigue, patients with GMG have significantly higher MG‐QoL and MGADL scores compared to patients with in pharmacological remission. *p ≤ .05, **p ≤ .01, ***p ≤ .001. GMG, generalized myasthenia gravis; OMG, ocular myasthenia gravis; CFQ, Chalder Fatigue Scale; MGQoL15, MG‐specific quality‐of‐life instrument; MGADL, MG activities of daily living profile